Jonathan Davies

Jonathan Davies

Cooley LLP

Contact
View Bio
RSS

Latest Posts › Section 5

Share:

Following Recent Policy Statement, FTC ‘Disputes’ 100+ Patent Listings in FDA Orange Book

The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA) Orange Book, stating that the FTC...more

11/22/2023  /  Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , FTC Act , Life Sciences , Orange Book , Patents , Pharmaceutical Patents , Section 5
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide